Spinal Cord Stimulation in Hypotensive Heart Failure Patients: Hemodynamic Assessment
Key facts
- Who runs it
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- Where
- Russia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 6 people enrolled
- Started
- 25 Mar 2022
- Ended
- 9 Jan 2024
- Type of study
- Interventional
- Treatments tested
- Spinal cord stimulation
- Record updated
- 6 March 2024
- Why it stopped
- No perceivable effect of transcutaneous spinal cord stimulation on blood pressure in heart failure patients
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age 18-75 years
- Patients with heart failure III-IV functional class (NYHA) with indications to right heart catheterization
- Systolic blood pressure <110/70 mm Hg when measured while sitting
- Patient who signed an informed consent form
Who cannot take part
- Transient ischemic event or stroke within 2 weeks prior to inclusion
- Any acute illness
- Epilepsy
- Hypovolemic status (central venous pressure <2 mm Hg)
- Pulmonary embolism <1 month ago
- An implanted infusion pump
- Pacemaker-dependent patients
- Patients who have contraindications to the use of the patch electrodes used in this study, as indicated in the respective instructions for use
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective single-center study that aims to evaluate the effects of non-invasive transcutaneous spinal cord stimulation on systemic and pulmonary hemodynamics, assessed during right heart catheterization in patients with heart failure and persistent or transient hypotension subjected to be included into the heart transplantation waiting list.
The group in the trial
- Spinal cord stimulation in heart failure patients with hypotensionTreatment being tested
Adhesive patches are applied to subjects' back skin. Single stimuli are delivered in order to define the stimulation threshold under the guidance of neuromyography. Vascular access is performed (jugular or subclavian) according to conventional preparation to right heart catheterization. Invasive hemodynamic measures are performed as usual. High-frequency spinal cord stimulation at T5 level is initiated, and repeated hemodynamic measures performed within 2 minutes. Stimulation lasts for 5-10 minutes, and then ceased. Following a 5-minutes waiting period, repeat hemodynamic measures are performed. The same sequence of steps applies for stimulation levels T7-8 and a combination of T5 and T7-8. Then the procedure is completed and data are analysed.
Treatment: Spinal cord stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Hemodynamic Effects of Transcutaneous Spinal Cord Stimulation in Patients With Chronic Heart Failure Undergoing Right Heart Catheterization for the Inclusion Into the Heart Transplantation Program: a Pilot Study
- Record updated
- 6 March 2024